Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Neuropathy".)
●(See "Society guideline links: Radiculopathy".)
●(See "Society guideline links: Complex regional pain syndrome".)
●(See "Society guideline links: Cancer pain".)
●(See "Society guideline links: Chronic pain management".)
International
●International Headache Society (IHS): International classification of headache disorders, 3rd edition (2018)
●World Health Organization (WHO): Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents (2018)
●International Association for the Study of Pain (IASP): Pharmacotherapy for neuropathic pain in adults – Systematic review, meta-analysis, and updated NeuPSIG recommendations (2015)
●International RDC/TMD Consortium Network and IASP: Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications (2014)
●IASP: Interventional management of neuropathic pain – NeuPSIG recommendations (2013)
●IASP: Guidelines and recommendations for assessment of somatosensory function in oro-facial pain conditions − A taskforce report (2011)
●IASP: NeuPSIG guidelines on neuropathic pain assessment (2011)
Canada
●The CanPain SCI Working Group: Clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury, 2021 update (published 2022)
●BC Guidelines: Palliative care for the patient with incurable cancer or advanced disease − Part 2: Pain and symptom management (2017)
●Cancer Care Ontario (CCO): Guidelines on management of pain in cancer and/or palliative care (2017)
●Canadian Pain Society (CPS): Revised consensus statement for the pharmacological management of chronic neuropathic pain (2014)
●CPS: Evidence-based guideline for neuropathic pain interventional treatments − Spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks (2012)
●Toronto Consensus Panel on Diabetic Neuropathy: Painful diabetic peripheral neuropathy – Consensus recommendations on diagnosis, assessment and management (2011)
United States
●American College of Radiology (ACR): ACR Appropriateness Criteria on cranial neuropathy (2022)
●Centers for Disease Control and Prevention (CDC): Clinical practice guideline for prescribing opioids for pain (2022)
●American Society of Clinical Oncology (ASCO): Clinical practice guideline for the prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers (2020)
●American Academy of Neurology (AAN): Assessment – Efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review) (2010, reaffirmed 2018)
●AAN: Practice advisory – Utility of surgical decompression for treatment of diabetic neuropathy (2006, reaffirmed 2018)
●AAN and European Federation of Neurological Societies (EFNS): Practice parameter – The diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review) (2008, reaffirmed 2018)
●American Society of Regional Anesthesia and Pain Medicine (ASRA), American Academy of Pain Medicine (AAPM), and American Society of Anesthesiologists (ASA): Consensus guidelines on the use of intravenous ketamine infusions for chronic pain (2018)
●Choosing Wisely: Don't choose opioids or narcotics as the first choice of treatment for neuropathic pain (2017)
●Choosing Wisely: Don't routinely use B vitamin supplements for the treatment of polyneuropathy or neuropathic pain unless a deficiency exists (2017)
●Infectious Diseases Society of America (IDSA): Clinical practice guideline for the management of chronic pain in patients living with HIV (2017)
●ASCO: Clinical practice guideline for management of chronic pain in survivors of adult cancers (2016)
●Congress of Neurological Surgeons (CNS): Systematic review and evidence-based guideline on occipital nerve stimulation for the treatment of patients with medically refractory occipital neuralgia (2015)
●AAN, American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM), and American Academy of Physical Medicine and Rehabilitation (AAPMR): Evidence-based guideline – Treatment of painful diabetic neuropathy (2011)
●Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain (2011)
Europe
●European Academy of Neurology (EAN): Guideline on trigeminal neuralgia (2019)
●European Headache Federation (EHF): Aids to management of headache disorders in primary care, 2nd edition (2019)
●American Academy of Neurology (AAN) and European Federation of Neurological Societies (EFNS): Practice parameter – The diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review) (2008, reaffirmed 2018)
●European Society for Medical Oncology (ESMO): Clinical practice guidelines for the management of cancer pain in adult patients (2018)
●EAN: Guidelines on central neurostimulation therapy in chronic pain conditions (2016)
●EFNS: Guidelines on neuropathic pain assessment, revised 2009 (published 2010)
●EFNS: Guidelines on the pharmacological treatment of neuropathic pain, revision (2010)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance for stereotactic radiosurgery for trigeminal neuralgia (2022)
●NICE: Clinical guideline on neuropathic pain in adults – Pharmacological management in non-specialist settings (2013, updated 2020)
●National Health Service Scotland (NHS Scotland): Scottish palliative care guidelines on neuropathic pain (2014, updated 2019)
●NICE: Medical technologies guidance for Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain (2019)
●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline for management of chronic pain (2013, revised 2019)
●NICE: Interventional procedures guidance for transcranial MRI-guided focused ultrasound thalamotomy for neuropathic pain (2018)
●NICE: Interventional procedures guidance for percutaneous electrical nerve stimulation for refractory neuropathic pain (2013)
Australia-New Zealand
●Choosing Wisely Australia: Avoid prescribing pregabalin and gabapentin for pain which does not fulfil the criteria for neuropathic pain (2018)
●Western Australian Therapeutic Advisory Group (WATAG): Guidelines for the pharmacological treatment of neuropathic pain (2017)
Japan
●[In Japanese] Japanese Association of Supportive Care in Cancer (JASCC): Clinical guide of management for chemotherapy-induced peripheral neuropathy (2017)
●[In English] The Japanese Society of Palliative Medicine (JSPM): Clinical guideline for pharmacological management of cancer pain − Recommendations (2013)
